Trial
NCT03056014
Antioxidant Use in Diabetes to Reduce Oxidative Stress
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Ameliorating Oxidative Stress in Type 1 Diabetes
Intervention
N-acetyl cysteine
Why stopped
COVID
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-22